HOME >> BIOLOGY >> NEWS
Calcium Channel Blocker Slows Hardening Of Arteries In Some Key Arteries, But Not Others

WINSTON-SALEM, N.C. -- A large clinical trial on whether a major calcium channel blocker could slow hardening of the arteries and thus reduce heart disease and stroke produced mixed results, a research team from the Wake Forest University School of Medicine and the University of Michigan reported today at the American Heart Association meeting.

The research team, headed by Curt D. Furberg, M.D., Ph.D. of Wake Forest and Bertram Pitt, M.D. of the University of Michigan, reported that amlodipine (Norvasc) had no significant effect in preventing new coronary artery atherosclerosis, hardening of the arteries, or on the progression of preexisting coronary artery atherosclerosis. However, it appeared to slow progression of atherosclerosis in the carotid arteries in the neck.

The coronary arteries supply blood to the heart, and a blocked coronary artery can lead to a heart attack. The carotid arteries provide blood to the brain, and a blocked carotid can lead to stroke.

There was no difference in the overall mortality, in rate of heart attack or stroke, or in major vascular "events" between patients on amlodipine and those on an inert placebo, which was consistent with a lack of effect on the coronary arteries, according to Robert P. Byington, Ph.D., associate professor of public health sciences and head of the section on epidemiology at Wake Forest, who headed the study's national data coordinating center.

But, Pitt, a professor of internal medicine, said, "Amlodipine significantly reduced the incidence of angina pectoris," severe chest pain that results from lack of oxygen to heart muscles.

Furberg, professor and chairman of public health sciences at Wake Forest and a national co-chairman of the study, noted, "This reduction in angina is a known symptomatic effect of amlodipine."

This reduction in symptoms led to fewer procedures to relieve angina, such as coronary artery bypass surgery. Becau
'"/>

Contact: Robert Conn, Jim Steele or Mark Wright
rconn@wfubmc.edu
336-716-4587
Wake Forest University Baptist Medical Center
11-Nov-1998


Page: 1 2 3

Related biology news :

1. Calcium supplements associated with decreased risk of large bowel polyps
2. Calcium channels control coronary artery relaxation
3. Calcium channel involved in coronary artery relaxation
4. Calcium signals found to guide nerve cell development
5. Calcium and Lead: should you worry?
6. Calcium absorption is not affected by a high protein diet
7. Calcium is not as readily absorbed from soy milk as from cows milk
8. Calcium not the only key to bone health in older women
9. Purdue Study: Calcium May Curb Weight Gain In Young Women
10. Trees Need Calcium Too
11. New England Journal Of Medicine Reports Calcium Supplements Help Prevent Polyp Recurrence; DMS Led Study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... ... August 03, 2020 , ... Accumen Inc. is helping ... equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. , ... for more than 10 years. Early in the COVID-19 crisis, we identified supply ...
(Date:7/22/2020)... Calif. (PRWEB) , ... July 21, 2020 , ... ... driving digital transformation and innovation in technology and compliance, announces a new solution ... device companies must ensure every layer of their technology stack complies with FDA ...
(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues ... An FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, ... the most effective way to complete one? Will the study comply with all ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... Inc. magazine today revealed ... prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique ... independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... making available for free its new white paper – Simulated Transport Methodologies. ... into today’s biologics licensing application (BLA). In response, Modality Solutions shares an ...
(Date:8/7/2020)... ... 06, 2020 , ... VGXI, a highly regarded CDMO supporting ... purchase of greenfield for a new, expanded manufacturing facility. The site is located ... the initial acquisition, with an option to purchase an additional 21 acres for ...
(Date:8/3/2020)... ... ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and positions its platform ... Biologics since its formation in 2016, the company is relaunching itself under the Ardent ... its base of innovative therapies for osteoarthritis and cancer. , ...
Breaking Biology Technology:
Cached News: